Meeting
2019 Genitourinary Cancers Symposium
Sarcopenia in bladder cancer patients is an unmodifiable outcomes predictor.
Authors
Gregory John Barton
Duke University Medical Center, Durham, NC
Gregory John Barton , Jeanette Wang , Andrew Chang , Wei Phin Tan , Joseph J Fantony , Paul E Wischmeyer , Rajan T. Gupta , Brant Allen Inman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 480)
DOI
10.1200/JCO.2019.37.7_suppl.480
Abstract #
480
Poster Bd #
L7
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Neoadjuvant chemotherapy-induced sarcopenia to predict perioperative complications following radical cystectomy for bladder cancer.
First Author: Miki Haifler
Poster
2017 Genitourinary Cancers Symposium
Discerning predictors for gender differences in survival outcomes for patients treated for bladder cancer.
First Author: Preston Kerr
Poster
2014 ASCO Annual Meeting
Previous cancer of spouse as a predictor for mortality after personal diagnosis of cancer.
First Author: Tamar Peretz
Poster
2024 ASCO Annual Meeting
Debunking the frailty-sarcopenia-ADT axis in metastatic prostate cancer with multicomponent exercise: The FIERCE trial.
First Author: Christina Marie Dieli-Conwright